By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

United Therapeutics Corporation 

1110 Spring Street

Silver Spring  Maryland  20910  U.S.A.
Phone: 301-608-9292 Fax: 301-608-9291


SEARCH JOBS


Industry
Biotechnology






Company News
United Therapeutics Corporation (UTHR) To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015 7/22/2015 11:38:31 AM
Dean Judy D. Olian Joins The United Therapeutics Corporation (UTHR) Board Of Directors 6/29/2015 7:34:35 AM
United Therapeutics Corporation (UTHR) Receives Paragraph IV Notice Letter For Tyvaso 6/15/2015 7:48:05 AM
United Therapeutics Corporation (UTHR) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/29/2015 7:42:21 AM
United Therapeutics Corporation (UTHR) Release: European Medicines Agency Recommends Treatment For Rare Cancer In Children 5/22/2015 9:40:41 AM
United Therapeutics Corporation (UTHR) To Present At The Deutsche Bank (DB) 40th Annual Health Care Conference 5/1/2015 9:34:52 AM
United Therapeutics Corporation (UTHR) Reports First Quarter 2015 Financial Results 4/28/2015 10:36:12 AM
United Therapeutics Corporation (UTHR) To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015 4/21/2015 10:06:07 AM
United Therapeutics Corporation (UTHR) Receives A Rare Pediatric Disease Priority Review Voucher Following The Approval Of Unituxin For Pediatric High-Risk Neuroblastoma 3/10/2015 10:03:05 AM
United Therapeutics Corporation (UTHR) Release: FDA Approves Unituxin (dinutuximab) For The Treatment Of Pediatric High-Risk Neuroblastoma 3/10/2015 9:40:43 AM
12345678910...
//-->